日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Response to therapy and prognosis according to molecular characterization in CALR-mutated essential thrombocythemia

根据 CALR 突变型原发性血小板增多症的分子特征评估治疗反应和预后

Santaliestra, Marta; Garrote, Marta; Fernández-Rodríguez, María Concepción; Vélez, Patricia; Senín, Alicia; Arellano-Rodrigo, Eduardo; Garcia-Gisbert, Neus; Longarón, Raquel; Pérez-Encinas, Manuel; Caballero-Navarro, Gonzalo; Noya-Pereira, Maria Soledad; Cuevas, Beatriz; Gómez-Casares, María Teresa; Stuckey, Ruth; Carreño-Tarragona, Gonzalo; Ferrer-Marin, Francisca; Cortés, Miguel Angel; Magro, Elena; Mata, Isabel; Angona, Anna; Pérez, Raúl; Fox, María Laura; Pastor-Galán, Irene; Sastre, Paula; Triguero, Ana; García-Gutierrez, Valentín; Hernández-Boluda, Juan Carlos; Bellosillo, Beatriz; Alvarez-Larran, Alberto

The JAK2V617F and CALR mutations and risk of cancer, cardiovascular diseases, and all-cause mortality

JAK2V617F 和 CALR 突变与癌症、心血管疾病和全因死亡率风险的关系

Larsen, Morten Kranker; Skov, Vibe; Kjær, Lasse; Eickhardt-Dalbøge, Christina Schjellerup; Knudsen, Trine Alma; Kristiansen, Marie Hvelplund; Sørensen, Anders Lindholm; Cordua, Sabrina; Wienecke, Troels; Jensen, Mette Grymer; Andersen, Morten; Ottesen, Johnny T; Gudmand-Høyer, Johanne; Snyder, Jordan Andrew; Poulsen, Henrik Enghusen; Stiehl, Thomas; Ellervik, Christina; Hasselbalch, Hans Carl

Recombinant CALR as a novel immune adjuvant in tumor immunotherapy

重组CALR作为肿瘤免疫治疗中的一种新型免疫佐剂

Ginley, Katelyn; Solanki, Shipra; Connington, Rachael A; Challagundla, Kishore B; Solanki, Ranjan

Recombinant CALR polarizes and activates macrophages in tumors.

重组 CALR 可极化并激活肿瘤中的巨噬细胞。

Manole Simin, Forbes Neil S

Low-dose DOX-polygodial nanosystem modulates the CD47/CALR axis for safer triple negative breast cancer treatment.

低剂量 DOX-聚角醛纳米系统调节 CD47/CALR 轴,实现更安全的三阴性乳腺癌治疗。

CALR/HIF-1α Positive Feedback Loop Drives CALR Upregulation to Promote EMT-Mediated Bladder Cancer Progression via ROS/AKT Axis

CALR/HIF-1α正反馈环路驱动CALR上调,通过ROS/AKT轴促进EMT介导的膀胱癌进展

Tian, Xintao; Liu, Yue; Mi, Zhiyuan; Liang, Ye; Zhang, Zhao; Ma, Xiaocheng; Jia, Huiqing; Cao, Yuxuan; Liang, Zhijuan; Yang, Shaonan; Ma, Guofeng; Niu, Haitao

CALR-mutant myeloproliferative neoplasms: insights from next-generation sequencing

CALR突变型骨髓增生性肿瘤:来自下一代测序的启示

Mroczkowska-Bękarciak, Aleksandra; Szeremet, Agnieszka; Chyrko, Olga; Wróbel, Tomasz

Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients

将 CALR 突变型原发性血小板增多症作为一种独立的疾病实体进行分析,并与 JAK2 V617F 突变型和三阴性患者进行比较。

Aydin, Gökhan Sami; Aksoy, Elif; Yönal Hindilerden, İpek; Dağlar Aday, Aynur; Gültürk, Emine; Nalçaci, Meliha; Hindilerden, Fehmi

CALR accelerates the growth of liver cancer cells by enhancing telomere activity via ARAF

CALR通过ARAF增强端粒活性,从而加速肝癌细胞的生长。

Xie, Sijie; Jiang, Xiaoxue; Liu, Xinlei; Song, Shuting; Wang, Liyan; Li, Shujie; Lu, Dongdong

Hypericin photoactivation induces triple-negative breast cancer cells pyroptosis by targeting the ROS/CALR/Caspase-3/GSDME pathway.

金丝桃素光活化通过靶向 ROS/CALR/Caspase-3/GSDME 通路诱导三阴性乳腺癌细胞焦亡。

Liang Chen, Liu Xiao, Yu Jie, Shi Lingyun, Wei Wenchao, Zhu Yalu, Feng Maoping, Tang Tingting, Li Dameng, Yang Tao, Zheng Junnian, Ma Bo, Wei Liang